Refractory or Recurrent Hypermutated Malignancies
1 clinical trials · Condition
◉ Watch Refractory or Recurrent Hypermutated Malignancies
| Record | Firm | Date |
|---|---|---|
| Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers (NCT02992964) | The Hospital for Sick Children | 2017-05-15 |
Track Refractory or Recurrent Hypermutated Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.